Organogenesis Holdings Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Accelerated filer
State of Incorporation
DE
Business Address
85 DAN ROAD, CANTON, MA, 02021
Mailing Address
85 DAN ROAD, CANTON, MA, 02021
Phone
781-575-0775
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$0.16
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4/A Insider transaction amendment | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
Annual Reports
10-K
February 26, 2026
- Solid 8% revenue growth in 2025, reaching $450 million.
- Successful launch of 'ReGenDerm' exceeding initial sales expectations.
Insider Trading
SELL
3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.